We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Mindray Expands Lab Chemistry and Hematology Product Offerings

By LabMedica International staff writers
Posted on 12 May 2009
Print article
New lab chemistry and hematology analyzers were launched at Mindray (Shenzen, China) product conference in April 2009, which took place in Shenzen, China. The products are intended to bridge the capabilities gap between mid- to high-output level labs.

The new BC-5300 and BC-5380 hematology analyzers are compact, economical, and free of daily maintenance. The analyzers require a 20-μl sampling volume, offer 5-part differentiation, and 27 measured parameters. Both analyzers use the impedance method for WBC, RBC, and PLT counting; feature semiconductor laser scatter combined with chemical dye method, and advanced flow cytometry. Also featured are whole blood and diluted counting modes, and the capability to flag abnormal samples. The analyzers process at a rate of 60 samples per hour. The BC-5380 features a 30-sample capacity autoloader and random access for improved walkaway automation, and close tube sampling functions. Throughput for closed tube sampling is 50 samples per hour.

The hematology analyzers include a local area network (LAN) port, come with user-friendly software featuring a variety of customizations for operations and reporting, have a data storage capacity for 40,000 results including graphical information, and support health level 7 (HL7) protocol.

The BS-380 Chemistry analyzer is a strategically positioned addition to the BS- family, has fully automated, discrete, random access functions for routine, STAT, urine and homogenous immunoassays. The chemistry analyzer can process 300 samples per hour.

The analyzer repertoire includes tests for proteins and immunoglobulins, nonprotein nitrogen, lipids, glucide, enzymes, electroloytes and minerals, and others. The sample tray has 75 positions, sample volume ranges from 2-45 μl stepped by 0.1 μl. The device comes with an optional internal barcode reader for sample and reagent programming. Reagents are held in a 2-8 ˚C-refrigerated compartment with 60 positions. The system features automatic dilution of abnormal samples, automatic probes cleaning, and 8-step autowashing. The optical system consists of Halogen-Tungsten lamp, with reversed optics grating photometry, and a range of 12 wavelengths from 340-800 nm.

The BS-380 includes support for RS-232 and bidirectional laboratory information systems (LIS) interface. The system displays real-time running status, and monitors reactions in real time.

According to the company, these products are in part the result of being responsive to customer feedback. Mr. Jie Liu, chief operating officer (COO) of Mindray said, "Mindray will continue to develop new products in the in vitro diagnostics field through continued focus on research and development.” "These [new] products elevate Mindray to the rank of a global player in the in vitro diagnostics field,” Mr. Liu added.

Mindray Medical International Limited is a leading developer, manufacturer, and marketer of medical devices in China with a significant and growing presence worldwide. Mindray offers a broad range of products across three primary business segments: patient monitoring devices, diagnostic laboratory instruments, and ultrasound imaging systems.

Related Links:

Mindray


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Toxoplasma Gondii Immunoassay
Toxo IgM AccuBind ELISA Kit
New
Vaginitis Test
Allplex Vaginitis Screening Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.